Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal
The French biotech Valneva will collaborate with Pfizer to develop and commercialize Valneva’s phase II-stage…
07/05/2020 - 4 minutes
Valneva
Update: Single-Shot Vaccine for Chikungunya Lasts for a Year in Phase I
Update (18/11/2019): French biotech Valneva has revealed additional phase I results concerning its experimental chikungunya…
18/11/2019 - 3 minutes
Overcoming Clinical Setbacks to Fight Insect-Borne Diseases
Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas…
04/09/2019 - 9 minutes
Phase I Gives Hope for First Zika Vaccine
Results from a Phase I trial showed promising safety and efficacy of a potential first…
20/11/2018 - 2 minutes
French Biotech Puts a New Lyme Disease Vaccine on the Horizon
There is currently no vaccine for the fast-growing disease in the US, & treatments cost…
12/12/2016 - 2 minutes
[Update] Valneva’s duck stem cells attract two new Vaccine-deals
French Valneva continues to sign license agreements for its duck derived stem cell line that produces…
28/08/2015 - 2 minutes
Valneva penetrates Chinese Market thanks to a license agreement
A few months ago, the article "An Anglo-French Partnership To Cure Hepatitis B" related Valneva…
18/03/2015 - 2 minutes
An Anglo-French Partnership To Cure Hepatitis B
European biotechnology company Valneva and UK company Immune Targeting Systems (ITS) announced that they have…
31/01/2015 - 2 minutes
